1.
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer . Clinics [Internet]. 2011 Jan. 1 [cited 2024 May 18];66(7):1143-7. Available from: https://revistas.usp.br/clinics/article/view/19352